Could crunching data from genomes and electronic health records prevent some of the thousands of U.S. infant deaths from preterm births? GNS Healthcare, a Big Data analytics firm, and Inova Translational Medicine Institute have embarked on a new project to create computer models that predict risk of preterm birth.
Comprehend Systems and GNS Healthcare made progress with very different software tools for drug researchers. Yet both companies have lived up to FierceBiotech IT 's choice to include them in an October 2011 report on tech companies to watch in the biotech arena.
GNS Healthcare has spent more than a decade refining computer analytics, with co-founder and CEO Colin Hill saying more than once that his company needs the right data to assemble models for personalized medicine.
GNS Healthcare has teamed up with Dana-Farber and Mount Sinai to build a Big Data-driven computer model of multiple myeloma. The project will combine GNS' computing power with data from next-generation sequencing to support the development of personalized medicines.
Covance ($CVD), the large contract research organization (CRO), has formed an alliance with the 'big data' analytics outfit GNS Healthcare to work on computer models to aid predictions on the success of clinical trials and to zero in on patients likely to benefit from experimental drugs.
The CHDI Foundation has put faith in the power of big-data analytics to address the lack of good drugs for Huntington's disease. The group has formed an alliance with GNS Healthcare to build computer models of the genetic brain disease for use in labs discovering potential new therapies.
Many companies are working on ways to crunch DNA data to interpret genomes, while others continue to tackle data-management problems in the biotech sphere with different solutions.
Biotech computing folks from around the world descended on Boston this week, and the FierceBiotech IT team was among them. Check out the slide show.
Selventa has embarked on a multiyear project to furnish healthcare giant Johnson & Johnson's ($JNJ) Janssen R&D group with disease models, in an effort to understand the mechanisms of...
Colin Hill has a new platform from which to speak out on "big data" analytics in healthcare and other hot topics. The CEO of GNS Healthcare, who should be known to many FierceBiotechIT...